{"id":57515,"date":"2024-02-27T17:47:54","date_gmt":"2024-02-27T17:47:54","guid":{"rendered":"https:\/\/medsname.com\/hyros\/"},"modified":"2026-05-01T10:49:14","modified_gmt":"2026-05-01T10:49:14","slug":"hyros","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/hyros\/","title":{"rendered":"Hyros"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Hyros?<\/h3>\n<p style=\"margin:0;\"><strong>Hyros<\/strong> je <strong>12.5 \/ 25 mg hydrochlorothiazide tablet<\/strong> from Zydus Cadila &mdash; a <strong>thiazide diuretic (benzothiadiazine sulfonamide)<\/strong> kter\u00fd p\u016fsob\u00ed na <strong>NCC (sodium-chloride cotransporter) in the distal convoluted tubule<\/strong>. Hydrochlorothiazide was introduced in 1959 by Merck Sharp &amp; Dohme as <strong>HydroDiuril<\/strong> &mdash; derived from sulfanilamide during the sulfonamide-antibiotic programme when its diuretic activity was noticed serendipitously. HCTZ became the reference thiazide and has been a first-line antihypertensive ever since. Half-life 6-15 hours; onset 2 hours; peak effect 4-6 hours; duration 6-12 hours. Primary indication: <strong>hypertension (first-line; guideline-recommended alongside ARB, ACEi, and CCB)<\/strong>. Typical dosing: Start 12.5 mg once daily in the morning. Target 12.5-25 mg. <strong>Do not exceed 25 mg<\/strong> for hypertension &mdash; higher doses give diminishing returns on BP but worsen metabolic side effects (urate, glucose, lipids). Modern guidelines have moved away from the historical 50 mg antihypertensive dose. Key contraindications: see full list below. Monitor electrolytes, creatinine, and glucose. <strong>Nekombinujte s lithiem<\/strong> (thiazidov\u00e1\/smy\u010dkov\u00e1 diuretika mohou vyvolat toxicitu lithia). <strong>U\u017eit\u00ed v t\u011bhotenstv\u00ed je p\u0159\u00edpad od p\u0159\u00edpadu<\/strong> (viz pozn\u00e1mka k t\u011bhotenstv\u00ed). U v\u011bt\u0161iny hypertonik\u016f funguj\u00ed diuretika nejl\u00e9pe jako <strong>druh\u00fd nebo t\u0159et\u00ed l\u00e9k<\/strong> \u2014 obvykle v kombinaci s ARB, ACE inhibitorem nebo blok\u00e1torem kalciov\u00fdch kan\u00e1l\u016f sp\u00ed\u0161e ne\u017e samostatn\u011b.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n<h2 class=\"wp-block-heading\">What Is Hyros?<\/h2>\n<p>Hyros is an oral 12.5 \/ 25 mg hydrochlorothiazide tablet from Zydus Cadila, supplied in 30-180 tablets. Hydrochlorothiazide was introduced in 1959 by Merck Sharp &amp; Dohme as <strong>HydroDiuril<\/strong> &mdash; derived from sulfanilamide during the sulfonamide-antibiotic programme when its diuretic activity was noticed serendipitously. HCTZ became the reference thiazide and has been a first-line antihypertensive ever since.<\/p>\n<h2 class=\"wp-block-heading\">How Hydrochlorothiazide Works<\/h2>\n<p>Hydrochlorothiazide inhibits the <strong>NCC (sodium-chloride cotransporter) in the distal convoluted tubule<\/strong>. N\u00e1sledn\u00e9 \u00fa\u010dinky:<\/p>\n<ul>\n<li><strong>Reduced sodium reabsorption<\/strong> in the distal convoluted tubule &mdash; a modest (~5%) increase in urinary sodium excretion<\/li>\n<li><strong>Volume contraction<\/strong> over the first 1-2 weeks &mdash; this is the dominant early BP-lowering mechanism<\/li>\n<li><strong>P\u0159\u00edm\u00e1 vazodilata\u010dn\u00ed aktivita<\/strong> developing over 2-6 weeks &mdash; the dominant long-term BP mechanism; thiazides at steady state reduce systemic vascular resistance independent of continued volume contraction<\/li>\n<li><strong>Enhanced distal-tubule calcium reabsorption<\/strong> &mdash; modestly raises serum calcium and reduces urinary calcium (exploited in calcium stone prevention)<\/li>\n<li><strong>Reduced free water clearance<\/strong> &mdash; can cause hyponatraemia in susceptible patients<\/li>\n<li><strong>Activation of the renin-angiotensin-aldosterone system<\/strong> as a compensatory response &mdash; partially blunts the BP effect of monotherapy; neutralised by combining with an ARB or ACE inhibitor (the rationale for FDCs like <a href=\"https:\/\/medsbase.com\/cs\/telma-h\/\">Telma H<\/a>, <a href=\"https:\/\/medsbase.com\/cs\/cosart-h\/\">Cosart H<\/a>)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Schv\u00e1len\u00e9 a v\u011bdecky podlo\u017een\u00e9 indikace<\/h2>\n<ul>\n<li><strong>Hypertension (first-line; guideline-recommended alongside ARB, ACEi, and CCB)<\/strong> \u2014 prim\u00e1rn\u00ed indikace<\/li>\n<li><strong>Mild heart failure oedema<\/strong> &mdash; step up to loop diuretic if not controlled<\/li>\n<li><strong>Recurrent calcium-containing kidney stones<\/strong> &mdash; 12.5-25 mg reduces calcium excretion and stone recurrence by 30-50%<\/li>\n<li><strong>Nephrogenic diabetes insipidus<\/strong> &mdash; paradoxical reduction in urine output at 25 mg BD<\/li>\n<li><strong>Osteopor\u00f3za<\/strong> &mdash; modest benefit via reduced urinary calcium loss (adjunctive only)<\/li>\n<\/ul>\n<p><strong>Kl\u00ed\u010dov\u00e9 d\u016fkazy z klinick\u00fdch studi\u00ed:<\/strong> <strong>ALLHAT (2002)<\/strong> &mdash; chlorthalidone (a close thiazide analogue) non-inferior to amlodipine and lisinopril for fatal and nonfatal cardiovascular endpoints in &gt;33,000 hypertensive patients; cemented thiazides as a first-line option. <strong>SHEP (1991)<\/strong> &mdash; chlorthalidone-based therapy reduced stroke by 36% in isolated systolic hypertension of the elderly. <strong>MRFIT, HDFP<\/strong> (1970s-80s) &mdash; earlier evidence base. HCTZ-specific large-scale hard-outcome data is weaker than chlorthalidone&rsquo;s but class effect is presumed.<\/p>\n<h2 class=\"wp-block-heading\">Hyros Dosage<\/h2>\n<p><strong>D\u00e1vka pro hypertenzi:<\/strong> Start 12.5 mg once daily in the morning. Target 12.5-25 mg. <strong>Do not exceed 25 mg<\/strong> for hypertension &mdash; higher doses give diminishing returns on BP but worsen metabolic side effects (urate, glucose, lipids). Modern guidelines have moved away from the historical 50 mg antihypertensive dose.<\/p>\n<p><strong>Dal\u0161\u00ed indikace:<\/strong> <strong>Mild heart failure oedema:<\/strong> 25-50 mg\/day; escalate to loop diuretic (furosemide) if not controlled. <strong>Idiopathic hypercalciuria (recurrent calcium stones):<\/strong> 12.5-25 mg\/day &mdash; thiazides promote distal-tubule calcium reabsorption and reduce stone recurrence by 30-50%. <strong>Nephrogenic diabetes insipidus:<\/strong> 25 mg twice daily paradoxically reduces urine output.<\/p>\n<p><strong>Pod\u00e1v\u00e1n\u00ed:<\/strong> jednou denn\u011b (nebo dvakr\u00e1t denn\u011b u vysok\u00fdch d\u00e1vek kli\u010dkov\u00fdch diuretik p\u0159i srde\u010dn\u00edm selh\u00e1n\u00ed), r\u00e1no. Ve\u010dern\u00ed pod\u00e1v\u00e1n\u00ed zp\u016fsobuje nykturii a m\u011blo by b\u00fdt pokud mo\u017eno vynech\u00e1no. U\u017e\u00edvejte ve stejnou denn\u00ed dobu. Potrava v\u00fdznamn\u011b neovliv\u0148uje vst\u0159eb\u00e1v\u00e1n\u00ed \u017e\u00e1dn\u00e9ho z t\u011bchto diuretik.<\/p>\n<p><strong>Monitorovac\u00ed pl\u00e1n:<\/strong><\/p>\n<ul>\n<li><strong>Vstupn\u00ed vy\u0161et\u0159en\u00ed:<\/strong> mo\u010dovina, elektrolyty (zejm\u00e9na drasl\u00edk a sod\u00edk), kreatinin, eGFR, gluk\u00f3za, s\u00e9rov\u00fd ur\u00e1t. Dom\u00e1c\u00ed nebo klinick\u00e9 m\u011b\u0159en\u00ed TK a denn\u00ed v\u00e1ha u pacient\u016f se srde\u010dn\u00edm selh\u00e1n\u00edm.<\/li>\n<li><strong>1-2 t\u00fddny po zah\u00e1jen\u00ed nebo zm\u011bn\u011b d\u00e1vky:<\/strong> opakujte U&amp;E a kreatinin. O\u010dek\u00e1vejte m\u00edrn\u00e9 zm\u011bny elektrolyt\u016f; vy\u0161et\u0159te v\u00fdrazn\u00e9 odchylky.<\/li>\n<li><strong>4-6 t\u00fddn\u016f:<\/strong> Kontrola krevn\u00edho tlaku a kompletn\u00ed metabolick\u00fd panel.<\/li>\n<li><strong>Pr\u016fb\u011b\u017en\u00e9:<\/strong> Ro\u010dn\u00ed vy\u0161et\u0159en\u00ed U&amp;E, ur\u00e1t\u016f, gluk\u00f3zy a lipidov\u00e9ho panelu po stabilizaci. \u010cast\u011bj\u0161\u00ed u CKD, srde\u010dn\u00edho selh\u00e1n\u00ed nebo p\u0159i kombinovan\u00e9 terapii.<\/li>\n<li><strong>P\u0159eru\u0161it l\u00e9\u010dbu nebo sn\u00ed\u017eit d\u00e1vkov\u00e1n\u00ed p\u0159i:<\/strong> sod\u00edk &lt;130 s p\u0159\u00edznaky, drasl\u00edk 5,5, vzestup kreatininu &gt;30 %, nov\u00e1 dna, p\u0159\u00edznaky t\u011b\u017ek\u00e9 dehydratace.<\/li>\n<\/ul>\n<p><strong>Ukon\u010den\u00ed l\u00e9\u010dby:<\/strong> \u017d\u00e1dn\u00fd abstinen\u010dn\u00ed syndrom, ale n\u00e1hl\u00e9 vysazen\u00ed m\u016f\u017ee zp\u016fsobit rebound retenci tekutin u pacient\u016f se srde\u010dn\u00edm selh\u00e1n\u00edm na chronick\u00e9 vysok\u00e9 d\u00e1vce kli\u010dkov\u00fdch diuretik \u2014 pokud mo\u017eno postupn\u011b sni\u017eovat a monitorovat hmotnost.<\/p>\n<ul>\n<li><strong>Loses efficacy at eGFR &lt;30.<\/strong> Switch to a loop diuretic (furosemide, torasemide) at advanced CKD &mdash; thiazides need functioning distal-tubule sodium delivery.<\/li>\n<li><strong>Raises serum calcium<\/strong> (paradoxical: thiazides enhance distal calcium reabsorption). Useful in osteoporotic patients; problematic in hypercalcaemic conditions (primary hyperparathyroidism, sarcoidosis).<\/li>\n<li><strong>Fotosensitivn\u00ed vyr\u00e1\u017eka<\/strong> is a specific thiazide class effect &mdash; counsel sun protection in sunny regions.<\/li>\n<li><strong>Sulfonamide cross-reactivity<\/strong> &mdash; avoid if severe sulfa allergy (rare; non-antibiotic sulfonamides rarely cross-react).<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Vedlej\u0161\u00ed \u00fa\u010dinky<\/h2>\n<p><strong>\u010cast\u00e9 (&gt;1 %):<\/strong><\/p>\n<ul>\n<li><strong>Hypokal\u00e9mie<\/strong> (3-5%) &mdash; more common at doses &gt;25 mg; largely prevented when combined with an ACEi\/ARB<\/li>\n<li><strong>Hyponatr\u00e9mie<\/strong> (2-5%) &mdash; especially in elderly women on low-salt diets; can be severe<\/li>\n<li><strong>Hyperurik\u00e9mie<\/strong> and gout precipitation<\/li>\n<li><strong>Modest worsening of glucose tolerance<\/strong> (fasting glucose +5-8 mg\/dL average)<\/li>\n<li><strong>Mild LDL and triglyceride rise<\/strong><\/li>\n<li><strong>Erektiln\u00ed dysfunkce<\/strong> in some men &mdash; dose-related<\/li>\n<li><strong>Hyperkalc\u00e9mie<\/strong> (usually mild)<\/li>\n<li><strong>Fotosensitivn\u00ed vyr\u00e1\u017eka<\/strong><\/li>\n<\/ul>\n<p><strong>Nep\u0159\u00edli\u0161 \u010dast\u00e9, ale klinicky v\u00fdznamn\u00e9:<\/strong><\/p>\n<ul>\n<li><strong>T\u011b\u017ek\u00e1 hyponatr\u00e9mie<\/strong> \u2014 zejm\u00e9na u star\u0161\u00edch osob na n\u00edzkosoln\u00fdch diet\u00e1ch, p\u0159i stavech n\u00e1chyln\u00fdch k SIADH nebo v kombinaci se SSRI. M\u016f\u017ee se projevit zmatenost\u00ed, p\u00e1dy nebo z\u00e1chvaty.<\/li>\n<li><strong>Pankreatitida<\/strong> \u2014 vz\u00e1cn\u00fd t\u0159\u00eddn\u00ed \u00fa\u010dinek thiazid\u016f\/smy\u010dkov\u00fdch diuretik; okam\u017eit\u011b vysadit p\u0159i bolesti v nadb\u0159i\u0161ku se vzestupem lip\u00e1zy<\/li>\n<li><strong>Trombocytopenie, leukopenie, agranulocyt\u00f3za<\/strong> \u2014 vz\u00e1cn\u00e9 hypersenzitivn\u00ed reakce (\u010dast\u011bj\u0161\u00ed u thiazid\u016f ne\u017e u smy\u010dkov\u00fdch diuretik)<\/li>\n<li><strong>Akutn\u00ed myopie a uzav\u0159en\u00fd \u00fahel glaukomu<\/strong> \u2014 vz\u00e1cn\u00e1 reakce sulfonamidov\u00e9 t\u0159\u00eddy b\u011bhem hodin a\u017e dn\u016f od za\u010d\u00e1tku pod\u00e1v\u00e1n\u00ed; okam\u017eit\u011b vysadit p\u0159i n\u00e1hl\u00e9 bolesti oka nebo zm\u011bn\u011b vid\u011bn\u00ed<\/li>\n<li><strong>Stevens-Johnson\u016fv syndrom \/ toxick\u00e1 epiderm\u00e1ln\u00ed nekrol\u00fdza<\/strong> \u2014 extr\u00e9mn\u011b vz\u00e1cn\u00e9, ale popsan\u00e9<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kontraindikace<\/h2>\n<ul>\n<li>Anuria or severe renal impairment (eGFR &lt;30) &mdash; loses efficacy<\/li>\n<li>Sulfonamide (sulfa) hypersensitivity<\/li>\n<li>Symptomatic hyponatraemia (Na &lt;130) or hypokalaemia (K &lt;3.0) at baseline<\/li>\n<li>Hyperkalc\u00e9mie<\/li>\n<li>T\u011b\u017ek\u00e9 jatern\u00ed po\u0161kozen\u00ed (Child-Pugh C)<\/li>\n<li>Addison disease (primary adrenal insufficiency)<\/li>\n<\/ul>\n<p><strong>T\u011bhotenstv\u00ed:<\/strong> obecn\u011b se nedoporu\u010duje \u2014 thiazidy proch\u00e1zej\u00ed placentou a mohou zp\u016fsobit novorozeneckou \u017eloutenku a trombocytopenii. Pou\u017e\u00edvat pouze pokud p\u0159\u00ednos jasn\u011b p\u0159eva\u017euje riziko (rezistentn\u00ed hypertenze v pozdn\u00edm t\u011bhotenstv\u00ed), pod odborn\u00fdm dohledem.<\/p>\n<p><strong>Kojen\u00ed:<\/strong> obecn\u011b p\u0159ijateln\u00e9 v n\u00edzk\u00fdch d\u00e1vk\u00e1ch; vysok\u00e9 d\u00e1vky mohou potla\u010dit laktaci (zejm\u00e9na thiazidy). Preferuj\u00ed se alternativn\u00ed antihypertenziva (propranolol, nifedipin), pokud je to mo\u017en\u00e9.<\/p>\n<h2 class=\"wp-block-heading\">Interakce s l\u00e9\u010divy<\/h2>\n<ul>\n<li><strong>Lithium \u2014 KRITICK\u00c1 INTERAKCE.<\/strong> Thiazidov\u00e1 a kli\u010dkov\u00e1 diuretika sni\u017euj\u00ed ren\u00e1ln\u00ed clearance lithia a mohou vyvolat lithiovou toxicitu. Pokud je to mo\u017en\u00e9, kombinaci se vyhn\u011bte; pokud je to nevyhnuteln\u00e9, monitorujte hladiny lithia t\u00fddn\u011b po prvn\u00ed m\u011bs\u00edc a sni\u017ete d\u00e1vku lithia o 25-50 %.<\/li>\n<li><strong>NSAID<\/strong> \u2014 sni\u017euj\u00ed diuretick\u00fd \u00fa\u010dinek (blok\u00e1dou prostaglandin\u016f) a v\u00fdrazn\u011b zvy\u0161uj\u00ed riziko akutn\u00edho po\u0161kozen\u00ed ledvin (AKI) v kombinaci s ACEi\/ARB (tzv. \u201ctriple whammy\u201d). P\u0159i chronick\u00e9 bolesti up\u0159ednost\u0148ujte paracetamol.<\/li>\n<li><strong>ACE inhibitory a ARB<\/strong> \u2014 tato kombinace je standardn\u00ed a prosp\u011b\u0161n\u00e1 u hypertenze; p\u0159id\u00e1n\u00ed ACEi\/ARB blokuje kompenza\u010dn\u00ed aktivaci RAAS a zesiluje diuretick\u00fd \u00fa\u010dinek. Monitorujte hladinu drasl\u00edku a kreatininu.<\/li>\n<li><strong>Drasl\u00edkov\u00e9 dopl\u0148ky a \u0161et\u0159\u00edc\u00ed diuretika<\/strong> \u2014 \u010dasto jsou pot\u0159eba k vyrovn\u00e1n\u00ed hypokal\u00e9mie vyvolan\u00e9 kli\u010dkov\u00fdmi\/thiazidov\u00fdmi diuretiky. Monitorujte hladinu drasl\u00edku; vyhn\u011bte se nadm\u011brn\u00e9 korekci.<\/li>\n<li><strong>Digoxin<\/strong> \u2014 hypokal\u00e9mie zesiluje toxicitu digoxinu (kli\u010dkov\u00e1 a thiazidov\u00e1 diuretika); spironolakton p\u0159\u00edmo sni\u017euje clearance digoxinu. Monitorujte hladiny digoxinu a drasl\u00edku p\u0159i zah\u00e1jen\u00ed nebo zm\u011bn\u011b diuretick\u00e9 l\u00e9\u010dby.<\/li>\n<li><strong>Peror\u00e1ln\u00ed kortikosteroidy, amfotericin B, stimula\u010dn\u00ed laxativa<\/strong> \u2014 aditivn\u00ed hypokal\u00e9mie (kli\u010dkov\u00e1\/thiazidov\u00e1 diuretika) nebo maskovan\u00e1 pot\u0159eba drasl\u00edku (spironolakton).<\/li>\n<li><strong>Peror\u00e1ln\u00ed antidiabetika, inzulin<\/strong> \u2014 thiazidy a (m\u00e9n\u011b) kli\u010dkov\u00e1 diuretika zhor\u0161uj\u00ed gluk\u00f3zovou toleranci; m\u016f\u017ee b\u00fdt nutn\u00e1 \u00faprava d\u00e1vkov\u00e1n\u00ed.<\/li>\n<li><strong>Cholestyramin \/ colestipol<\/strong> \u2014 sni\u017euj\u00ed absorpci thiazid\u016f a kli\u010dkov\u00fdch diuretik o 40\u201385%. D\u00e1vkov\u00e1n\u00ed odd\u011blte 4hodinov\u00fdm intervalem.<\/li>\n<li><strong>Alkohol<\/strong> \u2014 aditivn\u00ed ortostatick\u00e1 hypotenze.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Where Hyros Fits in the Diuretic Class<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:14px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">T\u0159\u00edda<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Z\u00e1stupci<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Typick\u00e9 pou\u017eit\u00ed<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background:#fff3cd;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Thiazid<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/cs\/aquazide\/\">HCTZ<\/a>, chlortalidon<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Prvn\u00ed volba u hypertenze, ledvinov\u00e9 kameny, nefrogenn\u00ed diabetes insipidus<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Thiazid\u016fm podobn\u00e9<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/cs\/natrilix-sr\/\">Indapamid<\/a>, metolazon<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Hypertenze (u star\u0161\u00edch pacient\u016f, d\u016fkazy z HYVET), sekven\u010dn\u00ed blok\u00e1da nefronu<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Kli\u010dkov\u00e1 (kr\u00e1tkodob\u00e1)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/cs\/lasix\/\">Furosemid<\/a>, bumetanide<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">bumetanid<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Akutn\u00ed plicn\u00ed ed\u00e9m, CHF, ascites, hyperkalc\u00e9mie<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/cs\/dytor\/\">Kli\u010dkov\u00e1 diuretika (dlouhodob\u00e1)<\/a><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Torasemid<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Chronick\u00e9 CHF, hypertenze (pouze kli\u010dkov\u00e1 diuretika s prok\u00e1zan\u00fdm \u00fa\u010dinkem p\u0159i hypertenzi), ed\u00e9m p\u0159i CKD<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/cs\/aldactone\/\">Spironolakton<\/a>, Antagonist\u00e9 aldosteronu<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">HF-REF (RALES), resistant HTN (PATHWAY-2), Conn\u2019s, cirrhotic ascites<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">eplerenon<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">HF-REF (RALES), rezistentn\u00ed hypertenze (PATHWAY-2), Conn\u016fv syndrom, cirhotick\u00fd ascites<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Ostatn\u00ed \u0161et\u0159\u00edc\u00ed drasl\u00edk<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Amilorid, triamteren (obvykle v kombinac\u00edch)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Prevence hypokal\u00e9mie p\u0159i p\u0159id\u00e1n\u00ed ke kli\u010dkov\u00fdm\/thiazidov\u00fdm diuretik\u016fm<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Inhibitory karboanhydr\u00e1zy<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Skladov\u00e1n\u00ed<\/h2>\n<p>Store Hyros below 25&deg;C in the original blister pack. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3 class=\"wp-block-heading\">When should I take Hyros &mdash; morning or evening?<\/h3>\n<p><strong>R\u00e1no<\/strong> in almost all cases. The diuretic effect produces increased urine output for 2-4 hours after dosing. Evening dosing causes nocturia and disrupts sleep. Patients on twice-daily loop diuretics typically dose at breakfast and early afternoon (not bedtime).<\/p>\n<h3 class=\"wp-block-heading\">Is Hyros a first-line blood-pressure drug?<\/h3>\n<p>Ano \u2014 thiazidy (HCTZ, chlortalidon) a thiazid\u016fm podobn\u00e9 l\u00e1tky (indapamid) pat\u0159\u00ed mezi <strong>\u010dty\u0159i t\u0159\u00eddy antihypertenziv prvn\u00ed volby<\/strong> vedle ARB, ACE inhibitor\u016f a blok\u00e1tor\u016f kalciov\u00fdch kan\u00e1l\u016f. U v\u011bt\u0161iny nov\u011b diagnostikovan\u00fdch hypertonik\u016f je thiazid rozumnou prvn\u00ed nebo druhou volbou a t\u00e9m\u011b\u0159 v\u0161ichni pacienti na v\u00edcel\u00e9kov\u00e9 terapii jej u\u017e\u00edvaj\u00ed.<\/p>\n<h3 class=\"wp-block-heading\">Will Hyros affect my potassium?<\/h3>\n<p>Yes &mdash; Hyros <strong>sni\u017euje<\/strong> drasl\u00edk zv\u00fd\u0161en\u00edm jeho vylu\u010dov\u00e1n\u00ed v dist\u00e1ln\u00edm tubulu. Monitorujte na za\u010d\u00e1tku, po 1-2 t\u00fddnech a periodicky. Riziko hypokal\u00e9mie je <strong>minimalizov\u00e1no kombinac\u00ed<\/strong> Hyros with an ARB or ACE inhibitor &mdash; which is the standard combination in hypertension anyway. If potassium drops below 3.5 in isolated diuretic use, add potassium supplementation, a potassium-rich diet, or a small dose of a potassium-sparing agent (spironolactone, eplerenone, or an <a href=\"https:\/\/medsbase.com\/cs\/amifru\/\">kombinaci obsahuj\u00edc\u00ed amilorid<\/a>).<\/p>\n<h3 class=\"wp-block-heading\">I have gout &mdash; can I take Hyros?<\/h3>\n<p>S opatrnost\u00ed. Thiazidy a (m\u00e9n\u011b) kli\u010dkov\u00e1 diuretika zvy\u0161uj\u00ed s\u00e9rovou hladinu kyseliny mo\u010dov\u00e9 konkurenc\u00ed o vylu\u010dov\u00e1n\u00ed v proxim\u00e1ln\u00edm tubulu. U pacient\u016f n\u00e1chyln\u00fdch k dn\u011b: preferujte kombinace s losartanem (<a href=\"https:\/\/medsbase.com\/cs\/cosart-h\/\">Cosart H<\/a>, <a href=\"https:\/\/medsbase.com\/cs\/cozartan-h\/\">Cozartan H<\/a>) whose losartan component is uniquely uricosuric and offsets the thiazide urate rise. If Hyros is already in use and gout flares, add or continue urate-lowering therapy (allopurinol) rather than stopping Hyros outright.<\/p>\n<h3 class=\"wp-block-heading\">I&rsquo;m diabetic &mdash; is Hyros safe?<\/h3>\n<p>Mostly yes, but be aware that thiazides and (to a lesser extent) loop diuretics <strong>modestly worsen glucose tolerance<\/strong> (average fasting glucose rise 5-8 mg\/dL, HbA1c 0.1-0.3%). The BP benefit outweighs this in most diabetics. If you want a more metabolically neutral combination, ARB+CCB is an alternative (<a href=\"https:\/\/medsbase.com\/cs\/olmezest-am\/\">Olmezest AM<\/a>).<\/p>\n<h3 class=\"wp-block-heading\">Can I take ibuprofen with Hyros?<\/h3>\n<p>Ob\u010dasn\u00e9 kr\u00e1tkodob\u00e9 u\u017e\u00edv\u00e1n\u00ed je obvykle v po\u0159\u00e1dku. Chronick\u00e9 denn\u00ed u\u017e\u00edv\u00e1n\u00ed NSAID (ibuprofen, diklofenak, naproxen) <strong>sni\u017euje diuretick\u00fd a antihypertenzn\u00ed \u00fa\u010dinek<\/strong> of Hyros (prostaglandin blockade) and substantially raise the AKI risk when combined with an ACE inhibitor or ARB &mdash; the &#8220;triple whammy.&#8221; Use paracetamol preferentially for chronic pain.<\/p>\n<h3 class=\"wp-block-heading\">Budu v noci v\u00edce mo\u010dit?<\/h3>\n<p>Usually no, if you take Hyros in the morning. The diuretic effect peaks 2-4 hours after dosing and has mostly worn off by evening. Nocturia is a common complaint when patients switch to evening dosing; switch back to morning dosing and nocturia resolves within 1-3 days.<\/p>\n<h3 class=\"wp-block-heading\">Can I take Hyros in pregnancy?<\/h3>\n<p>Routinely avoided. Thiazides cross the placenta and can affect the fetus. For hypertension in pregnancy, switch to <a href=\"https:\/\/medsbase.com\/cs\/labebet\/\">labetalol<\/a>, methyldopu nebo nifedipin. Diuretika se v t\u011bhotenstv\u00ed pou\u017e\u00edvaj\u00ed pouze pro specifick\u00e9 indikace (plicn\u00ed ed\u00e9m, rezistentn\u00ed srde\u010dn\u00ed selh\u00e1n\u00ed) pod dohledem specialisty.<\/p>\n<h3 class=\"wp-block-heading\">Co kdy\u017e vynech\u00e1m d\u00e1vku?<\/h3>\n<p>U\u017eijte ho, jakmile si vzpomenete, pokud ji\u017e nen\u00ed bl\u00edzko \u010das dal\u0161\u00ed d\u00e1vky \u2014 v tom p\u0159\u00edpad\u011b vynechejte zapomenutou d\u00e1vku. Nezdvojujte d\u00e1vku. Jedna vynechan\u00e1 d\u00e1vka v\u00fdznamn\u011b neovlivn\u00ed dlouhodobou kontrolu krevn\u00edho tlaku ani tekutin.<\/p>\n<h3 class=\"wp-block-heading\">Where can I buy Hyros online?<\/h3>\n<p>You can buy Hyros (12.5 \/ 25 mg hydrochlorothiazide, 30-180 tablets) from MedsBase with discreet packaging and worldwide shipping.<\/p>\n<h2 class=\"wp-block-heading\">Souvisej\u00edc\u00ed antihypertenziva a diuretika na MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/aquazide\/\">Aquazide &mdash; Hydrochlorothiazide (HCTZ) thiazide<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/cosart-h\/\">Cosart H &mdash; Losartan + HCTZ fixed combination<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/hydrocl\/\">Hydrocl \u2014 Hydrochlorothiazid (HCTZ)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/losar\/\">Losar \u2014 Losartan (ARB v kombinaci s diuretiky)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/ramcor\/\">Ramcor &mdash; Ramipril (ACEi partner for diuretic)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/silectone\/\">Silectone \u2014 Spironolakton (antagonista aldosteronu)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/high-blood-pressure-medication\/\"><strong>Prohl\u00e9dnout v\u0161echny l\u00e9ky na vysok\u00fd krevn\u00ed tlak<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 L\u00e9ka\u0159sk\u00e9 upozorn\u011bn\u00ed.<\/strong> Tato str\u00e1nka slou\u017e\u00ed pouze pro informa\u010dn\u00ed \u00fa\u010dely a nenahrazuje l\u00e9ka\u0159skou p\u00e9\u010di kvalifikovan\u00e9ho zdravotnick\u00e9ho pracovn\u00edka. Hypertenze, srde\u010dn\u00ed selh\u00e1n\u00ed a arytmie vy\u017eaduj\u00ed diagn\u00f3zu, monitorov\u00e1n\u00ed a individu\u00e1ln\u00ed d\u00e1vkov\u00e1n\u00ed l\u00e9ka\u0159em \u2014 v\u017edy u\u017e\u00edvejte betablok\u00e1tory pod l\u00e9ka\u0159sk\u00fdm dohledem.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Souvisej\u00edc\u00ed alternativy<\/h3>\n<p>Dal\u0161\u00ed produkty v <strong>Chronick\u00e1 onemocn\u011bn\u00ed<\/strong> kter\u00e9 z\u00e1kazn\u00edci tak\u00e9 prohl\u00ed\u017eej\u00ed:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/coversyl\/\">Coversyl<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/p-nolol\/\">P-Nolol<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/sazo\/\">Sazo<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/ciplar\/\">Ciplar<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/cort-s-injection\/\">Cort-S Injection<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Hyros is Zydus Cadila&#8217;s hydrochlorothiazide 12.5\/25 mg tablets \u2014 classic thiazide diuretic for hypertension (first-line class), mild heart-failure oedema, and recurrent calcium kidney stone prevention. Combines well with ARBs, ACE inhibitors, or calcium-channel blockers. Modern dose range 12.5-25 mg; higher doses give diminishing BP returns with worse metabolic side effects.<\/p>","protected":false},"featured_media":57516,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260,3356],"product_tag":[3401,4318],"class_list":{"0":"post-57515","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-heart-blood-pressure","9":"product_cat-high-blood-pressure-medication","10":"product_tag-hydrochlorothiazide","11":"product_tag-hyros","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/57515","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=57515"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/57516"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=57515"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=57515"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=57515"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=57515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}